{"id":13204,"date":"2024-10-07T14:00:15","date_gmt":"2024-10-07T14:00:15","guid":{"rendered":"https:\/\/fevas.org\/entrevista-a-miren-atuna\/"},"modified":"2025-02-14T09:00:20","modified_gmt":"2025-02-14T09:00:20","slug":"entrevista-a-miren-atuna","status":"publish","type":"post","link":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/","title":{"rendered":"Elkarrizketa Miren Atunari"},"content":{"rendered":"<!-- RS_MODULE_CODE_2.5.0 --><div id=\"readspeaker_button13204\" class=\"rs_skip rsbtn rs_preserve\"><a class=\"rsbtn_play\" title=\"Escucha esta p&aacute;gina utilizando ReadSpeaker\" accesskey=\"L\" href=\"https:\/\/app-eu.readspeaker.com\/cgi-bin\/rsent?customerid=8933&amp;lang=es_es&amp;readid=rspeak_read_13204&amp;url=https%3A%2F%2Ffevas.org%2Feu%2Fwp-json%2Fwp%2Fv2%2Fposts%2F13204%2F\"><span class=\"rsbtn_left rsimg rspart\"><span class=\"rsbtn_text\"><span>Escuchar<\/span><\/span><\/span><span class=\"rsbtn_right rsimg rsplay rspart\"><\/span><\/a><\/div><div id=\"rspeak_read_13204\"><p>Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.\u00a0Elkarrizketa honetan, Altunak adierazten du gizartea ez dagoela prest Down Sindromea duten pertsonen zahartzeak dakarren erronka bere gain hartzeko. Etapa honetan berariazko baliabiderik ez izateak gehiegizko instituzionalizazioa, polifarmazia edo ospitaleratze gehiago eragin ditzake.<\/p>\n<p>Bestalde, ikerketaren aldeko apustua egiteko beharra azpimarratu du, diagnostikoa, tratamendua eta, azken batean, pazienteen eta zaintzaileen bizi-kalitatea hobetzen laguntzen baitu.<\/p>\n<p><iframe title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/AcDEpSHps8Y?si=0pVrI4BycOThLmnp\" width=\"560\" height=\"515\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p><!-- RS_MODULE_CODE_2.5.0 --><\/p>\n<div id=\"readspeaker_button13204\" class=\"rs_skip rsbtn rs_preserve\"><a class=\"rsbtn_play\" title=\"Escucha esta p&aacute;gina utilizando ReadSpeaker\" accesskey=\"L\" href=\"https:\/\/app-eu.readspeaker.com\/cgi-bin\/rsent?customerid=8933&amp;lang=es_es&amp;readid=rspeak_read_13204&amp;url=https%3A%2F%2Ffevas.org%2Feu%2Fwp-json%2Fwp%2Fv2%2Fposts%2F13204%2F\"><span class=\"rsbtn_left rsimg rspart\"><span class=\"rsbtn_text\"><span>Escuchar<\/span><\/span><\/span><span class=\"rsbtn_right rsimg rsplay rspart\"><\/span><\/a><\/div>\n<div id=\"rspeak_read_13204\">Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.\n<\/div>\n","protected":false},"author":5,"featured_media":13375,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[],"class_list":["post-13204","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-eskubideak"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Elkarrizketa Miren Atunari | FEVAS Plena inclusi\u00f3n Euskadi<\/title>\n<meta name=\"description\" content=\"Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\" \/>\n<meta property=\"og:locale\" content=\"eu_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Elkarrizketa Miren Atunari | FEVAS Plena inclusi\u00f3n Euskadi\" \/>\n<meta property=\"og:description\" content=\"Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\" \/>\n<meta property=\"og:site_name\" content=\"FEVAS Plena inclusi\u00f3n Euskadi\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-07T14:00:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-14T09:00:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fevas.org\/wp-content\/uploads\/2024\/10\/Captura-de-pantalla-2024-10-31-101856.png\" \/>\n\t<meta property=\"og:image:width\" content=\"610\" \/>\n\t<meta property=\"og:image:height\" content=\"405\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Comunicacion FEVAS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Comunicacion FEVAS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\"},\"author\":{\"name\":\"Comunicacion FEVAS\",\"@id\":\"https:\/\/fevas.org\/#\/schema\/person\/f019920861119ca0b48233f93a8030a2\"},\"headline\":\"Elkarrizketa Miren Atunari\",\"datePublished\":\"2024-10-07T14:00:15+00:00\",\"dateModified\":\"2025-02-14T09:00:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\"},\"wordCount\":77,\"publisher\":{\"@id\":\"https:\/\/fevas.org\/#organization\"},\"articleSection\":[\"Eskubideak\"],\"inLanguage\":\"eu-ES\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\",\"url\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\",\"name\":\"Elkarrizketa Miren Atunari | FEVAS Plena inclusi\u00f3n Euskadi\",\"isPartOf\":{\"@id\":\"https:\/\/fevas.org\/#website\"},\"datePublished\":\"2024-10-07T14:00:15+00:00\",\"dateModified\":\"2025-02-14T09:00:20+00:00\",\"description\":\"Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.\",\"breadcrumb\":{\"@id\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/#breadcrumb\"},\"inLanguage\":\"eu-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\/\/fevas.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eskubideak\",\"item\":\"https:\/\/fevas.org\/eu\/category\/eskubideak\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Elkarrizketa Miren Atunari\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fevas.org\/#website\",\"url\":\"https:\/\/fevas.org\/\",\"name\":\"FEVAS Plena inclusi\u00f3n Euskadi\",\"description\":\"Somos una asociaci\u00f3n de entidades que trabaja por los derechos de las personas con discapacidad intelectual o del desarrollo y de sus familias\",\"publisher\":{\"@id\":\"https:\/\/fevas.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fevas.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"eu-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fevas.org\/#organization\",\"name\":\"FEVAS\",\"url\":\"https:\/\/fevas.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/fevas.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fevas.org\/wp-content\/uploads\/2024\/01\/fevas-logo.png\",\"contentUrl\":\"https:\/\/fevas.org\/wp-content\/uploads\/2024\/01\/fevas-logo.png\",\"width\":193,\"height\":162,\"caption\":\"FEVAS\"},\"image\":{\"@id\":\"https:\/\/fevas.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/fevas.org\/#\/schema\/person\/f019920861119ca0b48233f93a8030a2\",\"name\":\"Comunicacion FEVAS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"eu-ES\",\"@id\":\"https:\/\/fevas.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/60b2743f933f48ec5b628cd266d67d38cf811de5a5d8b5c2e17f6cdd60aade91?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/60b2743f933f48ec5b628cd266d67d38cf811de5a5d8b5c2e17f6cdd60aade91?s=96&d=mm&r=g\",\"caption\":\"Comunicacion FEVAS\"},\"url\":\"https:\/\/fevas.org\/eu\/author\/comunicacion\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Elkarrizketa Miren Atunari | FEVAS Plena inclusi\u00f3n Euskadi","description":"Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/","og_locale":"eu_ES","og_type":"article","og_title":"Elkarrizketa Miren Atunari | FEVAS Plena inclusi\u00f3n Euskadi","og_description":"Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.","og_url":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/","og_site_name":"FEVAS Plena inclusi\u00f3n Euskadi","article_published_time":"2024-10-07T14:00:15+00:00","article_modified_time":"2025-02-14T09:00:20+00:00","og_image":[{"width":610,"height":405,"url":"https:\/\/fevas.org\/wp-content\/uploads\/2024\/10\/Captura-de-pantalla-2024-10-31-101856.png","type":"image\/png"}],"author":"Comunicacion FEVAS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Comunicacion FEVAS","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/#article","isPartOf":{"@id":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/"},"author":{"name":"Comunicacion FEVAS","@id":"https:\/\/fevas.org\/#\/schema\/person\/f019920861119ca0b48233f93a8030a2"},"headline":"Elkarrizketa Miren Atunari","datePublished":"2024-10-07T14:00:15+00:00","dateModified":"2025-02-14T09:00:20+00:00","mainEntityOfPage":{"@id":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/"},"wordCount":77,"publisher":{"@id":"https:\/\/fevas.org\/#organization"},"articleSection":["Eskubideak"],"inLanguage":"eu-ES"},{"@type":"WebPage","@id":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/","url":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/","name":"Elkarrizketa Miren Atunari | FEVAS Plena inclusi\u00f3n Euskadi","isPartOf":{"@id":"https:\/\/fevas.org\/#website"},"datePublished":"2024-10-07T14:00:15+00:00","dateModified":"2025-02-14T09:00:20+00:00","description":"Neurologoa. Cita Alzheimer Fundazioko ikertzailea. Down sindromea eta Alzheimerra duten pertsonetan aditua. Aditu honekin zahartzea eta Alzheimer gaixotasuna Down Sindromea duten biztanleen artean gaiari helduko diogu: lehen sintomak, tratamendua, erronkak eta ikerketaren garrantzia.","breadcrumb":{"@id":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/#breadcrumb"},"inLanguage":"eu-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fevas.org\/eu\/entrevista-a-miren-atuna\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/fevas.org\/"},{"@type":"ListItem","position":2,"name":"Eskubideak","item":"https:\/\/fevas.org\/eu\/category\/eskubideak\/"},{"@type":"ListItem","position":3,"name":"Elkarrizketa Miren Atunari"}]},{"@type":"WebSite","@id":"https:\/\/fevas.org\/#website","url":"https:\/\/fevas.org\/","name":"FEVAS Plena inclusi\u00f3n Euskadi","description":"Somos una asociaci\u00f3n de entidades que trabaja por los derechos de las personas con discapacidad intelectual o del desarrollo y de sus familias","publisher":{"@id":"https:\/\/fevas.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fevas.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"eu-ES"},{"@type":"Organization","@id":"https:\/\/fevas.org\/#organization","name":"FEVAS","url":"https:\/\/fevas.org\/","logo":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/fevas.org\/#\/schema\/logo\/image\/","url":"https:\/\/fevas.org\/wp-content\/uploads\/2024\/01\/fevas-logo.png","contentUrl":"https:\/\/fevas.org\/wp-content\/uploads\/2024\/01\/fevas-logo.png","width":193,"height":162,"caption":"FEVAS"},"image":{"@id":"https:\/\/fevas.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fevas.org\/#\/schema\/person\/f019920861119ca0b48233f93a8030a2","name":"Comunicacion FEVAS","image":{"@type":"ImageObject","inLanguage":"eu-ES","@id":"https:\/\/fevas.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/60b2743f933f48ec5b628cd266d67d38cf811de5a5d8b5c2e17f6cdd60aade91?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/60b2743f933f48ec5b628cd266d67d38cf811de5a5d8b5c2e17f6cdd60aade91?s=96&d=mm&r=g","caption":"Comunicacion FEVAS"},"url":"https:\/\/fevas.org\/eu\/author\/comunicacion\/"}]}},"_links":{"self":[{"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/posts\/13204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/comments?post=13204"}],"version-history":[{"count":4,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/posts\/13204\/revisions"}],"predecessor-version":[{"id":13212,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/posts\/13204\/revisions\/13212"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/media\/13375"}],"wp:attachment":[{"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/media?parent=13204"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/categories?post=13204"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fevas.org\/eu\/wp-json\/wp\/v2\/tags?post=13204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}